ConductScience.org, home

Paper42650737

A Novel Antimicrobial Peptide Displaying Broad-Spectrum Activity Against Pan-Resistant Pathogens and Low Propensity for Resistance Development.

Temur BZ and 7 others. Antibiotics (Basel), 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. A Novel Antimicrobial Peptide Displaying Broad-Spectrum Activity Against Pan-Resistant Pathogens and Low Propensity for Resistance Development. Papers, record 42650737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42650737

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Novel Antimicrobial Peptide Displaying Broad-Spectrum Activity Against Pan-Resistant Pathogens and Low Propensity for Resistance Development.
PubMed
Journal
Antibiotics (Basel)
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-29
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Temur BZBetul Zehrahttps://orcid.org/0000-0003-4064-2537
2Bolat EEsmahttps://orcid.org/0000-0002-4742-4914
3Ayas MMeltem
4Demirci SNSengül Nisa
5Unubol NNihanhttps://orcid.org/0000-0003-4644-112X
6Yurttutan Uyar NNeval
7Can OOzge
8Kocagoz TTanilhttps://orcid.org/0000-0001-7211-2026

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
119C036Türkiye Bilimsel ve Teknolojik Araştırma KurumuPubMed
217S060Türkiye Bilimsel ve Teknolojik Araştırma KurumuPubMed

Source PubMed

Download CSV of grants

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132117132Resistance Evolution Against Antimicrobial Peptides in Staphylococcus aureus Alters Pharmacodynamics Beyond the MIC.Front Microbiol2020https://conductscience.org/library/papers/32117132PubMed
236980322Antibiotic Resistance Diagnosis in ESKAPE Pathogens-A Review on Proteomic Perspective.Diagnostics (Basel)2023https://conductscience.org/library/papers/36980322PubMed
335065702Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.Lancet2022https://conductscience.org/library/papers/35065702PubMed
431191496YhjX Regulates the Growth of Escherichia coli in the Presence of a Subinhibitory Concentration of Gentamicin and Mediates the Adaptive Resistance to Gentamicin.Front Microbiol2019https://conductscience.org/library/papers/31191496PubMed
531385762Antiviral Activities of Human Host Defense Peptides.Curr Med Chem2020https://conductscience.org/library/papers/31385762PubMed
634684258Bacterial Antibiotic Resistance: The Most Critical Pathogens.Pathogens2021https://conductscience.org/library/papers/34684258PubMed
739475864In vitro antibacterial activity of Morinda citrifolia extracts against eight pathogenic bacteria species.PLoS One2024https://conductscience.org/library/papers/39475864PubMed
821793988Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.Clin Microbiol Infect2012https://conductscience.org/library/papers/21793988PubMed
911168187EUCAST Definitive Document E.DEF 3.1, June 2000: Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution.Clin Microbiol Infect2000https://conductscience.org/library/papers/11168187PubMed
1040118976Antimicrobial activity of cephamycins and β-lactam/β-lactamase inhibitors against ESBL-producing Escherichia coli and Klebsiella pneumoniae under standard and high bacterial inocula.Sci Rep2025https://conductscience.org/library/papers/40118976PubMed
1140260375Global trends in antimicrobial resistance of Enterococcus faecium: a systematic review and meta-analysis of clinical isolates.Front Pharmacol2025https://conductscience.org/library/papers/40260375PubMed
1232257965Antifungal Peptides as Therapeutic Agents.Front Cell Infect Microbiol2020https://conductscience.org/library/papers/32257965PubMed
1322421877Modulating immunity as a therapy for bacterial infections.Nat Rev Microbiol2012https://conductscience.org/library/papers/22421877PubMed
1431941022Development and Challenges of Antimicrobial Peptides for Therapeutic Applications.Antibiotics (Basel)2020https://conductscience.org/library/papers/31941022PubMed
1528273381Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.Pharmacotherapy2017https://conductscience.org/library/papers/28273381PubMed
1639254296Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenem-polymyxin-resistant Klebsiella pneumoniae: an in vitro and in vivo analysis.Antimicrob Agents Chemother2024https://conductscience.org/library/papers/39254296PubMed
1736290075Antimicrobial Peptides-Mechanisms of Action, Antimicrobial Effects and Clinical Applications.Antibiotics (Basel)2022https://conductscience.org/library/papers/36290075PubMed
1839894233Novel antibacterial agents and emerging therapies in the fight against multidrug-resistant Acinetobacter baumannii.Microb Pathog2025https://conductscience.org/library/papers/39894233PubMed
1933106260Systematic Investigation of Resistance Evolution to Common Antibiotics Reveals Conserved Collateral Responses across Common Human Pathogens.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/33106260PubMed
2021573784Multifunctional cationic host defence peptides and their clinical applications.Cell Mol Life Sci2011https://conductscience.org/library/papers/21573784PubMed

See all 25 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42650737

GET https://conductscience.org/api/papers/v1/42650737/references?page=2